IGLV5-45

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, IGLV5-45 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated IGLV5-45 data layer compared with 1 for mutation status and 3 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher IGLV5-45 RNA is associated with better overall survival. In most high-consensus cancer types, elevated IGLV5-45 expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, SKCM, and KIRP are the cancer types where IGLV5-45 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCOSMedianAll0.7590.614<.001137view →
SKCMDFSTertileAll0.6900.526<.001123view →
KIRPDFSTertileII,III,IV0.4930.853.00161view →
UCECDFSQuartileIII,IV0.6990.116<.00154view →
UVMDFSTertileAll0.4020.806.00236view →
LIHCDFSTertileAll0.6170.428<.00135view →
LUADDFSQuartileII,III,IV0.7980.415.00335view →
SARCOSMedianAll0.8910.785.00134view →
BRCADFSQuartileAll0.6220.462.00430view →
LGGDFSTertileAll0.6540.794.01621view →
CHOLDFSMedianAll0.7000.189.00518view →
COADDFSTertileIII,IV0.7100.397.02814view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

Exploration